Veszprém, Hungary

Tibor Szanya

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszerarugyar Rt. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tibor Szanya. Retrieved from https://idiyas.com/inventor/tibor-szanya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tibor Szanya: Innovator in Cyclosporin A Purification

Introduction

Tibor Szanya is a notable inventor based in Veszprem, Hungary. He has made significant contributions to the field of pharmaceutical purification processes. His work focuses on enhancing the efficiency of extracting valuable compounds from complex mixtures.

Latest Patents

Tibor Szanya holds a patent for a process for the purification of cyclosporin A. This innovative method involves solution chromatographic purification from a starting mixture that may contain various cyclosporin components and contaminants. The process includes heating the starting mixture to a temperature between 80°C and 115°C, melting it, and then performing solution chromatography using specific solvent mixtures.

Career Highlights

Tibor Szanya is associated with Biogal Gyogyszerarugyar Rt, a company dedicated to pharmaceutical development. His expertise in purification processes has positioned him as a valuable asset in the industry. He has successfully developed methods that improve the quality and yield of pharmaceutical products.

Collaborations

Tibor has collaborated with several professionals in his field, including Laszlo Hanak and Gyongyi Strbka. These collaborations have fostered innovation and advancement in pharmaceutical research and development.

Conclusion

Tibor Szanya's contributions to the purification of cyclosporin A exemplify his commitment to advancing pharmaceutical sciences. His innovative methods continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…